Literature DB >> 22169125

Carotid intima-media thickness among human immunodeficiency virus-infected patients without coronary calcium.

Priscilla Y Hsue1, Karen Ordovas, Theodore Lee, Gautham Reddy, Michael Gotway, Amanda Schnell, Jennifer E Ho, Van Selby, Erin Madden, Jeffrey N Martin, Steven G Deeks, Peter Ganz, David D Waters.   

Abstract

Subjects infected with human immunodeficiency virus (HIV) have increased risk for atherosclerosis. Carotid artery intima-media thickness (IMT) assessed using ultrasound and coronary artery calcium (CAC) detected using computed tomography predict cardiovascular risk in the general population; however, their usefulness and comparability in patients with HIV are less well defined. The purpose of this study was to compare IMT and CAC in the detection of atherosclerosis in subjects with HIV. CAC and IMT were measured in 253 HIV-infected and 58 uninfected adults. Associations among HIV-related factors, traditional risk factors, and CAC and IMT were evaluated. The distribution of IMT among subjects with and without CAC was compared. Among the patients with HIV, 37% had detectable CAC compared to 28% of controls (p = 0.19); 16% of the patients with HIV had CAC >100 compared to 5% of controls (p = 0.03). With either detectable or undetectable CAC, HIV-infected subjects had higher IMT compared to controls (1.02 ± 0.34 vs 0.78 ± 0.12 mm, p <0.0001), even after adjustment for traditional risk factors. Among those with undetectable CAC, 34% of patients with HIV had markedly increased IMT (≥1 mm) compared to no controls (p <0.0001). HIV-related factors were associated with IMT but not with CAC. In conclusion, patients with HIV and controls had similar rates of detectable CAC, while absolute CAC scores were modestly higher in the HIV group. Conversely, carotid IMT detected advanced subclinical atherosclerosis in patients with HIV even in the absence of CAC. Thus, with HIV, IMT is associated with disease-related factors and may be a more sensitive indicator of subclinical atherosclerosis than CAC. Copyright Â
© 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22169125      PMCID: PMC3640832          DOI: 10.1016/j.amjcard.2011.10.036

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  20 in total

1.  Both long-term HIV infection and highly active antiretroviral therapy are independent risk factors for early carotid atherosclerosis.

Authors:  M W Lorenz; C Stephan; A Harmjanz; S Staszewski; A Buehler; M Bickel; S von Kegler; D Ruhkamp; H Steinmetz; M Sitzer
Journal:  Atherosclerosis       Date:  2007-02-01       Impact factor: 5.162

2.  Coronary aging in HIV-infected patients.

Authors:  Giovanni Guaraldi; Stefano Zona; Nikolaos Alexopoulos; Gabriella Orlando; Federica Carli; Guido Ligabue; Federica Fiocchi; Antonella Lattanzi; Rosario Rossi; Maria Grazia Modena; Roberto Esposito; Frank Palella; Paolo Raggi
Journal:  Clin Infect Dis       Date:  2009-12-01       Impact factor: 9.079

3.  Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (Atherosclerosis Risk In Communities) study.

Authors:  Vijay Nambi; Lloyd Chambless; Aaron R Folsom; Max He; Yijuan Hu; Tom Mosley; Kelly Volcik; Eric Boerwinkle; Christie M Ballantyne
Journal:  J Am Coll Cardiol       Date:  2010-04-13       Impact factor: 24.094

Review 4.  A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association.

Authors:  H C Stary; A B Chandler; R E Dinsmore; V Fuster; S Glagov; W Insull; M E Rosenfeld; C J Schwartz; W D Wagner; R W Wissler
Journal:  Circulation       Date:  1995-09-01       Impact factor: 29.690

5.  Subclinical coronary atherosclerosis, HIV infection and antiretroviral therapy: Multicenter AIDS Cohort Study.

Authors:  Lawrence A Kingsley; Juliana Cuervo-Rojas; Alvaro Muñoz; Frank J Palella; Wendy Post; Mallory D Witt; Matthew Budoff; Lewis Kuller
Journal:  AIDS       Date:  2008-08-20       Impact factor: 4.177

6.  Preclinical atherosclerosis due to HIV infection: carotid intima-medial thickness measurements from the FRAM study.

Authors:  Carl Grunfeld; Joseph A C Delaney; Christine Wanke; Judith S Currier; Rebecca Scherzer; Mary L Biggs; Phyllis C Tien; Michael G Shlipak; Stephen Sidney; Joseph F Polak; Daniel O'Leary; Peter Bacchetti; Richard A Kronmal
Journal:  AIDS       Date:  2009-09-10       Impact factor: 4.177

7.  Calcium begets calcium: progression of coronary artery calcification in asymptomatic subjects.

Authors:  Hyo-Chun Yoon; Aletha M Emerick; Jennifer A Hill; David W Gjertson; Jonathan G Goldin
Journal:  Radiology       Date:  2002-07       Impact factor: 11.105

8.  Coronary calcium as a predictor of coronary events in four racial or ethnic groups.

Authors:  Robert Detrano; Alan D Guerci; J Jeffrey Carr; Diane E Bild; Gregory Burke; Aaron R Folsom; Kiang Liu; Steven Shea; Moyses Szklo; David A Bluemke; Daniel H O'Leary; Russell Tracy; Karol Watson; Nathan D Wong; Richard A Kronmal
Journal:  N Engl J Med       Date:  2008-03-27       Impact factor: 91.245

Review 9.  Vascular calcification: mechanisms and clinical ramifications.

Authors:  Moeen Abedin; Yin Tintut; Linda L Demer
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-05-20       Impact factor: 8.311

10.  Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection.

Authors:  Priscilla Y Hsue; Joan C Lo; Arlana Franklin; Ann F Bolger; Jeffrey N Martin; Steven G Deeks; David D Waters
Journal:  Circulation       Date:  2004-03-15       Impact factor: 29.690

View more
  29 in total

1.  Direct Targeting of Macrophages With Methylglyoxal-Bis-Guanylhydrazone Decreases SIV-Associated Cardiovascular Inflammation and Pathology.

Authors:  Joshua A Walker; Andrew D Miller; Tricia H Burdo; Michael S McGrath; Kenneth C Williams
Journal:  J Acquir Immune Defic Syndr       Date:  2017-04-15       Impact factor: 3.731

Review 2.  Inflammation, immune activation, and cardiovascular disease in HIV.

Authors:  Eric Nou; Janet Lo; Steven K Grinspoon
Journal:  AIDS       Date:  2016-06-19       Impact factor: 4.177

Review 3.  HIV Infection and Risk of Cardiovascular Diseases Beyond Coronary Artery Disease.

Authors:  Revery P Barnes; John Charles A Lacson; Hossein Bahrami
Journal:  Curr Atheroscler Rep       Date:  2017-05       Impact factor: 5.113

Review 4.  Cardiovascular Complications of HIV in Endemic Countries.

Authors:  Matthew J Feinstein; Milana Bogorodskaya; Gerald S Bloomfield; Rajesh Vedanthan; Mark J Siedner; Gene F Kwan; Christopher T Longenecker
Journal:  Curr Cardiol Rep       Date:  2016-11       Impact factor: 2.931

5.  Genetic polymorphisms associated with carotid artery intima-media thickness and coronary artery calcification in women of the Kronos Early Estrogen Prevention Study.

Authors:  Virginia M Miller; Tanya M Petterson; Elysia N Jeavons; Abhinita S Lnu; David N Rider; John A Heit; Julie M Cunningham; Gordon S Huggins; Howard N Hodis; Matthew J Budoff; Nanette Santoro; Paul N Hopkins; Rogerio A Lobo; JoAnn E Manson; Frederick Naftolin; Hugh S Taylor; S Mitchell Harman; Mariza de Andrade
Journal:  Physiol Genomics       Date:  2012-11-27       Impact factor: 3.107

6.  HIV vasculopathy: role of mononuclear cell-associated Krüppel-like factors 2 and 4.

Authors:  Andrew T Hale; Chris T Longenecker; Ying Jiang; Sara M Debanne; Danielle E Labatto; Norma Storer; Anne Hamik; Grace A McComsey
Journal:  AIDS       Date:  2015-08-24       Impact factor: 4.177

7.  Effects of aging and smoking on carotid intima-media thickness in HIV-infection.

Authors:  Kathleen V Fitch; Sara E Looby; Alison Rope; Peace Eneh; Linda Hemphill; Hang Lee; Steven K Grinspoon
Journal:  AIDS       Date:  2013-01-02       Impact factor: 4.177

8.  Plasma IL-6 levels are independently associated with atherosclerosis and mortality in HIV-infected individuals on suppressive antiretroviral therapy.

Authors:  Denise C Hsu; Yi Fei Ma; Sophia Hur; Danny Li; Adam Rupert; Rebecca Scherzer; S C Kalapus; Steven Deeks; Irini Sereti; Priscilla Y Hsue
Journal:  AIDS       Date:  2016-08-24       Impact factor: 4.177

9.  Non-classical monocytes predict progression of carotid artery bifurcation intima-media thickness in HIV-infected individuals on stable antiretroviral therapy.

Authors:  Dominic C Chow; Jamie M Kagihara; Guangxiang Zhang; Scott A Souza; Howard N Hodis; Yanjie Li; Brooks I Mitchell; Beau K Nakamoto; Kalpana J Kallianpur; Sheila M Keating; Philip J Norris; Lindsay B Kohorn; Lishomwa C Ndhlovu; Cecilia M Shikuma
Journal:  HIV Clin Trials       Date:  2016-04-04

10.  The metabolic and cardiovascular consequences of obesity in persons with HIV on long-term antiretroviral therapy.

Authors:  John R Koethe; Heather Grome; Cathy A Jenkins; Spyros A Kalams; Timothy R Sterling
Journal:  AIDS       Date:  2016-01-02       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.